*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck - as a primary diagnosis code | C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck - as a primary or secondary diagnosis code | |
---|---|---|
OUTCOMES | ||
Avg. LOS | 6.22 | |
Readmission Rate (%) | 23.99 | |
Unplanned Readmission Rate (%) | 8.0 | |
Mortality Rate (%) | ||
SNF Discharge Rate (%) | ||
Home Discharge Rate (%) | ||
PAYMENTS AND CHARGES | ||
Total Medicare Payments | ||
Payment Per Day | ||
Payment Per Hospitalization | ||
Total Medicare Charges | ||
Avg. Charges | ||
MARKET SIZING & INCIDENCE RATES | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations after Exclusion |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 822: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 821: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 824: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 825: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 823: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 3,219 | ||||
Total Hospitalizations with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 1,850 | ||||
DRG Share of Total Hospitalizations | 0.01 | ||||
% of Total ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck in DRG | 40.38 | ||||
Avg LOS at DRG | 2.37 | ||||
Avg LOS with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 1.83 | ||||
Readmission Rate at DRG | 10.84 | ||||
Readmission Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 6.28 | ||||
Unplanned Readmission Rate at DRG | 4.86 | ||||
Unplanned Readmission Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 3.06 | ||||
Total Medicare payments at DRG | $26,522,582 | ||||
Total Medicare payments with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $15,349,803 | ||||
Total Medicare payment per Day at DRG | $3,474 | ||||
Total Medicare payment per Day with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $4,536 | ||||
Total Medicare payment per Hospitalization at DRG | $8,239 | ||||
Total Medicare payment per Hospitalization with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $8,297 | ||||
Total Medicare Charges at DRG | $163,247,266 | ||||
Total Medicare Charges with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $82,807,273 | ||||
Avg Charges at DRG | $50,714 | ||||
Avg Charges with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $44,761 | ||||
Mortality Rate at DRG | NA | ||||
Mortality Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | NA | ||||
SNF Discharge Rate at DRG | 1.99 | ||||
SNF Discharge Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 1.08 | ||||
Home Discharge Rate at DRG | 85.49 | ||||
Home Discharge Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 90.32 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 841: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH COMPLICATION OR COMORBIDITY (CC) | DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 820: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 842: LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 011: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 25,646 | ||||
Total Hospitalizations with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 203 | ||||
DRG Share of Total Hospitalizations | 0.08 | ||||
% of Total ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck in DRG | 4.43 | ||||
Avg LOS at DRG | 5.67 | ||||
Avg LOS with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 5.0 | ||||
Readmission Rate at DRG | 36.28 | ||||
Readmission Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 32.11 | ||||
Unplanned Readmission Rate at DRG | 22.95 | ||||
Unplanned Readmission Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 23.16 | ||||
Total Medicare payments at DRG | $299,718,477 | ||||
Total Medicare payments with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $2,365,914 | ||||
Total Medicare payment per Day at DRG | $2,062 | ||||
Total Medicare payment per Day with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $2,331 | ||||
Total Medicare payment per Hospitalization at DRG | $11,687 | ||||
Total Medicare payment per Hospitalization with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $11,655 | ||||
Total Medicare Charges at DRG | $1,432,739,779 | ||||
Total Medicare Charges with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $8,141,585 | ||||
Avg Charges at DRG | $55,866 | ||||
Avg Charges with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $40,106 | ||||
Mortality Rate at DRG | 2.6 | ||||
Mortality Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | NA | ||||
SNF Discharge Rate at DRG | 13.23 | ||||
SNF Discharge Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 11.33 | ||||
Home Discharge Rate at DRG | 49.84 | ||||
Home Discharge Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 48.77 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 012: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | |
---|---|
Total Hospitalizations at DRG | 5,976 |
Total Hospitalizations with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 20 |
DRG Share of Total Hospitalizations | 0.02 |
% of Total ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck in DRG | 0.44 |
Avg LOS at DRG | 9.73 |
Avg LOS with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 8.75 |
Readmission Rate at DRG | 28.1 |
Readmission Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | NA |
Unplanned Readmission Rate at DRG | 12.26 |
Unplanned Readmission Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | NA |
Total Medicare payments at DRG | $173,115,606 |
Total Medicare payments with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $558,050 |
Total Medicare payment per Day at DRG | $2,978 |
Total Medicare payment per Day with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $3,189 |
Total Medicare payment per Hospitalization at DRG | $28,968 |
Total Medicare payment per Hospitalization with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $27,903 |
Total Medicare Charges at DRG | $862,569,965 |
Total Medicare Charges with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $2,906,103 |
Avg Charges at DRG | $144,339 |
Avg Charges with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $145,305 |
Mortality Rate at DRG | 0.38 |
Mortality Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | NA |
SNF Discharge Rate at DRG | 17.35 |
SNF Discharge Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | NA |
Home Discharge Rate at DRG | 22.74 |
Home Discharge Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | NA |
Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 143 |
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 103 |
MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114 | 95 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. GREGORY S WEINSTEIN | 3400 SPRUCE ST | PHILADELPHIA | PA | 19104 | 51 |
Dr. ERIC JOSEPH LENTSCH | 171 ASHLEY AVE | CHARLESTON | SC | 29425 | 32 |
Dr. KEVIN S EMERICK | 1500 EAST MEDICAL CENTER DR | ANN ARBOR | MI | 48109 | 29 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. GREGORY S WEINSTEIN | 3400 SPRUCE ST | PHILADELPHIA | PA | 19104 | 52 |
Dr. ERIC JOSEPH LENTSCH | 171 ASHLEY AVE | CHARLESTON | SC | 29425 | 31 |
Dr. KEVIN S EMERICK | 1500 EAST MEDICAL CENTER DR | ANN ARBOR | MI | 48109 | 29 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 129: MAJOR HEAD AND NECK PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) OR MAJOR DEVICE | DRG 822: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 012: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 821: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 626: THYROID, PARATHYROID AND THYROGLOSSAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 6,332 | ||||
Total Hospitalizations with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 2,287 | ||||
DRG Share of Total Hospitalizations | 0.02 | ||||
% of Total ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck in DRG | 8.31 | ||||
Avg LOS at DRG | 5.14 | ||||
Avg LOS with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 4.1 | ||||
Readmission Rate at DRG | 14.35 | ||||
Readmission Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 12.38 | ||||
Unplanned Readmission Rate at DRG | 7.64 | ||||
Unplanned Readmission Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 5.94 | ||||
Total Medicare payments at DRG | $113,818,459 | ||||
Total Medicare payments with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $38,787,763 | ||||
Total Medicare payment per Day at DRG | $3,496 | ||||
Total Medicare payment per Day with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $4,135 | ||||
Total Medicare payment per Hospitalization at DRG | $17,975 | ||||
Total Medicare payment per Hospitalization with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $16,960 | ||||
Total Medicare Charges at DRG | $599,317,955 | ||||
Total Medicare Charges with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $190,789,916 | ||||
Avg Charges at DRG | $94,649 | ||||
Avg Charges with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $83,424 | ||||
Mortality Rate at DRG | 0.74 | ||||
Mortality Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | NA | ||||
SNF Discharge Rate at DRG | 9.41 | ||||
SNF Discharge Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 5.73 | ||||
Home Discharge Rate at DRG | 64.53 | ||||
Home Discharge Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 72.23 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 011: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 133: OTHER EAR, NOSE, MOUTH AND THROAT O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 987: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 1,808,415 | ||||
Total Hospitalizations with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 945 | ||||
DRG Share of Total Hospitalizations | 5.5 | ||||
% of Total ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck in DRG | 3.43 | ||||
Avg LOS at DRG | 6.34 | ||||
Avg LOS with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 7.11 | ||||
Readmission Rate at DRG | 24.2 | ||||
Readmission Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 27.96 | ||||
Unplanned Readmission Rate at DRG | 16.78 | ||||
Unplanned Readmission Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 21.49 | ||||
Total Medicare payments at DRG | $21,288,214,047 | ||||
Total Medicare payments with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $12,910,022 | ||||
Total Medicare payment per Day at DRG | $1,857 | ||||
Total Medicare payment per Day with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $1,921 | ||||
Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
Total Medicare payment per Hospitalization with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $13,661 | ||||
Total Medicare Charges at DRG | $107,155,481,388 | ||||
Total Medicare Charges with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $68,441,126 | ||||
Avg Charges at DRG | $59,254 | ||||
Avg Charges with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $72,424 | ||||
Mortality Rate at DRG | 12.11 | ||||
Mortality Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 19.58 | ||||
SNF Discharge Rate at DRG | 27.18 | ||||
SNF Discharge Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 15.77 | ||||
Home Discharge Rate at DRG | 25.81 | ||||
Home Discharge Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 21.38 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 827: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 824: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 577: SKIN GRAFT EXCEPT FOR SKIN ULCER OR CELLULITIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 825: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 147: EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 4,469 | ||||
Total Hospitalizations with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 451 | ||||
DRG Share of Total Hospitalizations | 0.01 | ||||
% of Total ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck in DRG | 1.64 | ||||
Avg LOS at DRG | 6.1 | ||||
Avg LOS with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 2.75 | ||||
Readmission Rate at DRG | 18.8 | ||||
Readmission Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 9.75 | ||||
Unplanned Readmission Rate at DRG | 10.96 | ||||
Unplanned Readmission Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 6.12 | ||||
Total Medicare payments at DRG | $78,385,486 | ||||
Total Medicare payments with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $7,333,058 | ||||
Total Medicare payment per Day at DRG | $2,876 | ||||
Total Medicare payment per Day with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $5,919 | ||||
Total Medicare payment per Hospitalization at DRG | $17,540 | ||||
Total Medicare payment per Hospitalization with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $16,260 | ||||
Total Medicare Charges at DRG | $393,997,363 | ||||
Total Medicare Charges with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $29,173,470 | ||||
Avg Charges at DRG | $88,162 | ||||
Avg Charges with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $64,686 | ||||
Mortality Rate at DRG | 0.58 | ||||
Mortality Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | NA | ||||
SNF Discharge Rate at DRG | 8.32 | ||||
SNF Discharge Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 4.66 | ||||
Home Discharge Rate at DRG | 63.15 | ||||
Home Discharge Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 81.15 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 181: RESPIRATORY NEOPLASMS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 823: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 146: EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 988: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 37,484 | ||||
Total Hospitalizations with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 313 | ||||
DRG Share of Total Hospitalizations | 0.11 | ||||
% of Total ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck in DRG | 1.14 | ||||
Avg LOS at DRG | 4.49 | ||||
Avg LOS with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 4.48 | ||||
Readmission Rate at DRG | 27.89 | ||||
Readmission Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 28.32 | ||||
Unplanned Readmission Rate at DRG | 21.07 | ||||
Unplanned Readmission Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 22.73 | ||||
Total Medicare payments at DRG | $287,773,529 | ||||
Total Medicare payments with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $2,615,819 | ||||
Total Medicare payment per Day at DRG | $1,709 | ||||
Total Medicare payment per Day with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $1,864 | ||||
Total Medicare payment per Hospitalization at DRG | $7,677 | ||||
Total Medicare payment per Hospitalization with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $8,357 | ||||
Total Medicare Charges at DRG | $1,483,578,942 | ||||
Total Medicare Charges with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $12,779,619 | ||||
Avg Charges at DRG | $39,579 | ||||
Avg Charges with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | $40,829 | ||||
Mortality Rate at DRG | 4.3 | ||||
Mortality Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 4.15 | ||||
SNF Discharge Rate at DRG | 10.7 | ||||
SNF Discharge Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 10.86 | ||||
Home Discharge Rate at DRG | 44.82 | ||||
Home Discharge Rate with ICD C770 - Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | 42.49 |
Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 775 |
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 436 |
THE UNIVERSITY OF CHICAGO MEDICAL CENTER | 5841 S. MARYLAND AVE | CHICAGO | IL | 60637 | 384 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. GREGORY S WEINSTEIN | 3400 SPRUCE ST | PHILADELPHIA | PA | 19104 | 114 |
Dr. ERIC GENDEN | 5 E 98TH ST | NEW YORK | NY | 10029 | 74 |
Dr. DANIEL J HARAF | 5841 S MARYLAND AVE # MC1099 | CHICAGO | IL | 60637 | 73 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. GREGORY S WEINSTEIN | 3400 SPRUCE ST | PHILADELPHIA | PA | 19104 | 118 |
Dr. ERIC GENDEN | 5 E 98TH ST | NEW YORK | NY | 10029 | 79 |
Dr. ERIC J MOORE | 200 1ST ST SW | ROCHESTER | MN | 55905 | 72 |